Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Baxter
Accenture
Harvard Business School
Boehringer Ingelheim
Moodys
Dow
Teva

Generated: April 22, 2018

DrugPatentWatch Database Preview

RAUDIXIN Drug Profile

« Back to Dashboard

Which patents cover Raudixin, and what generic alternatives are available?

Raudixin is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in RAUDIXIN is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Drug patent expirations by year for RAUDIXIN
Synonyms for RAUDIXIN
(7aR,8S,11aS,12aS)-8-Methyl-5,6,7a,8,11a,12,12a,13-octahydro-7H-9-oxa-6a,13-diaza-indeno[2,1-a]anthracene-11-carboxylic acid methyl ester
16,17-Didehydro-19-methyloxayohimban-16-carboxylic acid methyl ester
19-Epiajmalicine
19b-methyl-16-methoxycarbonyl-16,17-didehydro-oxayohimbane
4-27-00-07927 (Beilstein Handbook Reference)
483-04-5
483A045
4QJL8OX71Z
AC-20175
AC1L9C1B
ACon1_001630
Ajmalicin
Ajmalicine
Ajmalicine(-Yohimbine)
AJN
AKOS015895125
Alkaloid C
Alkaloid F
Alkaloid II
API0004044
BDBM50030612
Bio-0252
BPBio1_000512
BRD-K83028735-001-01-6
BRD-K83028735-003-03-8
BRN 0097268
BSPBio_000464
BT000576
C09024
C21H24N2O3
CAS-4373-34-6
CAS-6474-90-4
CHEBI:2524
CHEMBL123325
Circolene
D08470
D0U7GP
delta-Yohimbine
DivK1c_006521
DR001793
EINECS 207-589-5
GRTOGORTSDXSFK-XJTZBENFSA-N
GTPL8746
Hydrosarpan
KBio1_001465
KBio2_001255
KBio2_003823
KBio2_006391
KBioSS_001255
Lamuran
Lamuran (TN)
LS-15651
LS-187727
MEGxp0_001818
Methyl (19-methyl-16,17-dehydro-18-oxa-3alpha,15alpha,19beta,20beta-yohimban-16-carboxylat)
Methyl (19alpha)-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate
methyl (19alpha)-19-methyl-16,17-didehydrooxayohimban-16-carboxylate
METHYL (1S,15R,16S,20S)-16-METHYL-17-OXA-3,13-DIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,18-PENTAENE-19-CARBOXYLATE
Methyl 16,17-didehydro-19alpha-methyl-18-oxayohimban-16-carboxylat
MFCD00042748
NCGC00016647-01
NCGC00016647-02
NCGC00016647-03
NCGC00016647-04
NSC 72133
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-.alpha).-
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)-
Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19-alpha)- (9CI)
Oxayohimban-16-carboxylicacid, 16,17-didehydro-19-methyl-, methyl ester, (19a)-
PL057365
Prestwick0_000592
Prestwick1_000592
Prestwick2_000592
Prestwick3_000592
py-Tetrahydroserpentine
Ranitol
Raubaserp
Raubasil
Raubasin
Raubasine
Raubasine (DCF)
Raumalina
Rauvasan
rauwolfia alkaloid
RAUWOLFIA SERPENTINA ROOT
Sarpan
SC-80963
SCHEMBL309914
SPBio_002683
SpecPlus_000425
Spectrum_000775
Substance II
Tensyl
Tetrahydroalstonine
Tetrahydroserpentine
UNII-4QJL8OX71Z
Vincain
Vincein
Vinceine
W-106052
ZINC53147422

US Patents and Regulatory Information for RAUDIXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon RAUDIXIN rauwolfia serpentina root TABLET;ORAL 008842-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon RAUDIXIN rauwolfia serpentina root TABLET;ORAL 008842-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Cantor Fitzgerald
Dow
Baxter
Julphar
Cerilliant
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.